Acta Cardiol 1996;51(5):381-94.
Application of mapping of cardiac electrical activity to the pharmacology.
D'Alche EP,
Universite, Caen, France.
J Cardiovasc Electrophysiol 1999 May;10(5):670-9.
Dispersion of filtered P wave duration by P wave signal-averaged ECG
mapping system: its usefulness for determining efficacy of disopyramide on
paroxysmal atrial fibrillation.
Kubara I, Ikeda H, Hiraki T, Yoshida T, Ohga M, Imaizumi T,
Department of Internal Medicine III and the Cardiovascular Research
Institute, Kurume University School of Medicine, Japan.
J Cardiovasc Electrophysiol 2000 Apr;11(4):396-404.
Body surface distribution and response to drugs of ST segment elevation in
Brugada syndrome: clinical implication of eighty-seven-lead body surface
potential mapping and its application to twelve-lead electrocardiograms.
Shimizu W, Matsuo K, Takagi M, Tanabe Y, Aiba T, Taguchi A, Suyama K, Kurita T, Aihara N, Kamakura S,
Department of Internal Medicine, National Cardiovascular Center, Suita,
Osaka, Japan. wshimizu@hsp.ncvc.go.jp